Browsing "1. Journal Papers" by Author : 271

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 60 of 177

This table browses all dspace content
Issue DateTitleJournal Title
2003A Case of Paraneoplastic Nephrotic Syndrome in a Patient with Ovarian Carcinoma YONSEI MEDICAL JOURNAL
2010A phase I pharmacokinetic and pharmacodynamic study of CKD-732, an antiangiogenic agent, in patients with refractory solid cancerINVESTIGATIONAL NEW DRUGS
2012A phase I pharmacokinetic study of TSU-68 (a multiple tyrosine kinase inhibitor of VEGFR-2, FGF and PDFG) in combination with S-1 and oxaliplatin in metastatic colorectal cancer patients previously treated with chemotherapyINVESTIGATIONAL NEW DRUGS
2012A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapyINVESTIGATIONAL NEW DRUGS
2009A phase II feasibility study of weekly paclitaxel in heavily pretreated advanced gastric cancer patients with poor performance statusONCOLOGY
2010A phase II study of a combined biweekly irinotecan and monthly cisplatin treatment for metastatic or recurrent gastric cancer.AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
2006A Phase II Study of Infusional 5-Fluorouracil and Low-Dose Leucovorin with Docetaxel for Advanced Gastric CancerONCOLOGY
2008A phase II study of paclitaxel combined with infusional 5-fluorouracil and low-dose leucovorin for advanced gastric cancer.CANCER CHEMOTHERAPY AND PHARMACOLOGY
2007A phase II study of S-1 monotherapy administered for 2 weeks of a 3-week cycle in advanced gastric cancer patients with poor performance status BRITISH JOURNAL OF CANCER
2006A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens BRITISH JOURNAL OF CANCER
2007A phase II trial of weekly fractionated irinotecan and cisplatin for advanced gastric cancerCANCER CHEMOTHERAPY AND PHARMACOLOGY
2005A Pilot Study of Trans-Arterial Injection of 166Holmium-Chitosan Complex for Treatment of Small Hepatocellular Carcinoma YONSEI MEDICAL JOURNAL
2009A prospective, multicenter, phase 2 study of imatinib mesylate in korean patients with metastatic or unresectable gastrointestinal stromal tumorONCOLOGY
2011A randomized phase 2 study of docetaxel and S-1 versus docetaxel and cisplatin in advanced gastric cancer with an evaluation of SPARC expression for personalized therapy CANCER
2015A Randomized Phase 2 Study of Neoadjuvant Chemoradiaton Therapy With 5-Fluorouracil/Leucovorin or Irinotecan/S-1 in Patients With Locally Advanced Rectal CancerINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2004Adeno-associated virus mediated endostatin gene therapy in combination with topoisomerase inhibitor effectively controls liver tumor in mouse model WORLD JOURNAL OF GASTROENTEROLOGY
2010Adenocarcinoma of the small bowel at a single Korean institute: management and prognosticatorsJOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
2011Advanced detection of recent changing trends in gastric cancer survival: up-to-date comparison by period analysis. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
1998Alpha-fetoprotein-producing gastric cancerONCOLOGY REPORTS
2007An association between RRM1 haplotype and gemcitabine-induced neutropenia in breast cancer patients ONCOLOGIST
2000Angiocentric lymphoma of the head and neck: Patterns of systemic failure after radiation treatmentJournal of Clinical Oncology
2004Angiocentric T-cell and NK/T-cell lymphomas: radiotherapeutic viewpointsINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2013Application of the Adjuvant! Online Model to Korean Breast Cancer Patients: An Assessment of Prognostic Accuracy and Development of an Alternative Prognostic ToolANNALS OF SURGICAL ONCOLOGY
2012Application of the Western-based adjuvant online model to Korean colon cancer patients; a single institution experience BMC CANCER
2009Association of the ABCB1 gene polymorphisms 2677G>T/A and 3435C>T with clinical outcomes of paclitaxel monotherapy in metastatic breast cancer patients ANNALS OF ONCOLOGY
2007Bilateral Breast Cancer: Differential Diagnosis Using Histological and Biological Parameters JAPANESE JOURNAL OF CLINICAL ONCOLOGY
2011Brain metastases from colorectal carcinoma: prognostic factors and outcomeJOURNAL OF NEURO-ONCOLOGY
2008Capecitabine and doxorubicin combination chemotherapy as salvage therapy in pretreated advanced gastric cancer.CANCER CHEMOTHERAPY AND PHARMACOLOGY
2005cDNA 미세배열 비교게놈교잡법 (cDNA microarray-based comparative genomic hybridization)을 이용한 염색체 이상 질환의 최신 고속 산전 유전 진단 Korean Journal of Obstetrics and Gynecology (대한산부인과학회지)
2009Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer NEW ENGLAND JOURNAL OF MEDICINE
2009Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial.LANCET
2007Cetuximab rescue a patient with non-small cell lung cancer from rapid disease progression during chemotherapyACTA ONCOLOGICA
2017Changes in telomerase activity due to alternative splicing of human telomerase reverse transcriptase in colorectal cancer ONCOLOGY LETTERS
1999Changes of telomerase and telomere lengths in paired normal and cancer tissues of breastInternational Journal of Oncology
2007Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: A 15-year follow-up study at a single korean instituteANNALS OF SURGICAL ONCOLOGY
2013Changing treatment patterns in elderly patients with resectable colon cancerASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
1994Changing trends in histologic types of lung cancer during the last decade(1981-1990) in Korean Hospital-based studyLUNG CANCER
2010Chemokine growth-regulated oncogene 1 as a putative biomarker for gastric cancer progressionCANCER SCIENCE
2008Chemoradiotherapy with or without consolidation chemotherapy using cisplatin and 5-fluorouracil in anal squamous cell carcinoma: long-term results in 31 patients BMC CANCER
2010Circulating endothelial progenitor cells (EPC) for tumor vasculogenesis in gastric cancer patientsCANCER LETTERS
2013Circulating vascular endothelial growth factor receptor 2/pAkt-positive cells as a functional pharmacodynamic marker in metastatic colorectal cancers treated with antiangiogenic agentINVESTIGATIONAL NEW DRUGS
2009Clinical features and treatment outcomes of advanced stage primary hepatic angiosarcoma ANNALS OF ONCOLOGY
2002Clinical lmplication of functional genomics in cancer.Biochemistry News (생화학뉴스)
2004Clinical relevance of three subtypes of primary sinonasal lymphoma characterized by immunophenotypic analysisHEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
2008Clinical Significance of Margin Status in Postoperative Radiotherapy for Extremity and Truncal Soft-Tissue SarcomaINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2009Clinical value of ezrin expression in primary osteosarcoma CANCER RESEARCH AND TREATMENT
2010Clinicopathologic features of metachronous or synchronous gastric cancer patients with three or more primary sites CANCER RESEARCH AND TREATMENT
2013Combination of CYP inhibitor with MEK/ERK inhibitor enhances the inhibitory effect on ERK in BRAF mutant colon cancer cells.ANTICANCER RESEARCH
1999Combined pre-operative chemotherapy with intra-arterial cisplatin and continuous intravenous adriamycin for high grade osteosarcomaONCOLOGY REPORTS
1997Comparison of biological phenotypes according to midkine expression in gastric cancer cells and their autocrine activities could be modulated by pentosan polysulfateCANCER LETTERS
2011Comparison of long-term outcome between doublet and triplet neoadjuvant chemotherapy in non-metastatic osteosarcoma of the extremityONCOLOGY
2009Copy number changes can be a predictor for hemoglobin reduction after S-1 monotherapy in gastric cancerINTERNATIONAL JOURNAL OF ONCOLOGY
1997Correlation between K-ras gene mutation and prognosis of patients with nonsmall cell lung carcinomaCANCER
2000Correlation of tissue and blood plasminogen activation system in breast cancerJournal of Neurology, Neurosurgery and Psychiatry
2017Dalotuzumab in chemorefractory KRAS exon 2 mutant colorectal cancer: Results from a randomised phase II/III trial INTERNATIONAL JOURNAL OF CANCER
1998Different expression patterns of MMP-2 and MMP-9 in breast cancerONCOLOGY REPORTS
2005Different role of functional domains of hTR in DNA binding to telomere and telomerase reconstruction FEBS LETTERS
2000E1B 55kD 유전자 결손 아데노바이러스의 종양 특이 증식 및 살상능 검증. Journal of the Korean Cancer Association (대한암학회지)
2001Early Postoperative Intraperitoneal Chemotherapy with Mitomycin C, 5-Fluorouracil and Cisplatin for Advanced Gastric CancerONCOLOGY
1999Effects of interleukin-2 transduction on the human hepatoma cell lines using retroviral vectorONCOLOGY REPORTS

Browse

Links